Industry Research Reports

Home > Reports > Machinery & Equipment > Pharma Continuous Granulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Pharma Continuous Granulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Machinery & Equipment

Published Date: 2026-01-19

Pages: 122 Pages

Report ld: 5724872

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pharma Continuous Granulation cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.

The North American market for Pharma Continuous Granulation was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Pharma Continuous Granulation was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Pharma Continuous Granulation was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Pharma Continuous Granulation market include LB Bohle, GEA, LCI, LÖDIGE, Senieer, Thermo Fisher Scientific, Syntegon, Gericke, Bepex, EARTHTECHNICA, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Pharma Continuous Granulation, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Pharma Continuous Granulation market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharma Continuous Granulation.

MARKET SEGMENTATION

By Company

LB Bohle
GEA
LCI
LÖDIGE
Senieer
Thermo Fisher Scientific
Syntegon
Gericke
Bepex
EARTHTECHNICA
Glatt
FREUND
Chansemt

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Dry Method
Wet Method

Segment by Application

Tablets
Capsules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Pharma Continuous Granulation manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Pharma Continuous Granulation sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Pharma Continuous Granulation sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pharma Continuous Granulation Product Introduction

1.2 Global Pharma Continuous Granulation Market Size Forecast

1.2.1 Global Pharma Continuous Granulation Sales Value (2021–2032)

1.2.2 Global Pharma Continuous Granulation Sales Volume (2021–2032)

1.2.3 Global Pharma Continuous Granulation Sales Price (2021–2032)

1.3 Pharma Continuous Granulation Market Trends & Drivers

1.3.1 Pharma Continuous Granulation Industry Trends

1.3.2 Pharma Continuous Granulation Market Drivers & Opportunities

1.3.3 Pharma Continuous Granulation Market Challenges

1.3.4 Pharma Continuous Granulation Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pharma Continuous Granulation Players Revenue Ranking (2025)

2.2 Global Pharma Continuous Granulation Revenue by Company (2021–2026)

2.3 Global Pharma Continuous Granulation Sales Volume Ranking of Players (2025)

2.4 Global Pharma Continuous Granulation Sales Volume by Company (2021–2026)

2.5 Global Pharma Continuous Granulation Average Price by Company (2021–2026)

2.6 Key Manufacturers Pharma Continuous Granulation Manufacturing Base and Headquarters

2.7 Key Manufacturers Pharma Continuous Granulation Product Offerings

2.8 Key Manufacturers Start of Mass Production of Pharma Continuous Granulation

2.9 Pharma Continuous Granulation Market Competitive Analysis

2.9.1 Pharma Continuous Granulation Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Pharma Continuous Granulation Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharma Continuous Granulation revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Pharma Continuous Granulation Market Classification

3.1 Introduction by Type

3.1.1 Dry Method

3.1.2 Wet Method

3.1.3 Global Pharma Continuous Granulation Sales Value by Type

3.1.3.1 Global Pharma Continuous Granulation Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Pharma Continuous Granulation Sales Value, by Type (2021–2032)

3.1.3.3 Global Pharma Continuous Granulation Sales Value, by Type (%), 2021–2032

3.1.4 Global Pharma Continuous Granulation Sales Volume by Type

3.1.4.1 Global Pharma Continuous Granulation Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Pharma Continuous Granulation Sales Volume, by Type (2021–2032)

3.1.4.3 Global Pharma Continuous Granulation Sales Volume, by Type (%), 2021–2032

3.1.5 Global Pharma Continuous Granulation Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Capsules

4.1.3 Others

4.2 Global Pharma Continuous Granulation Sales Value by Application

4.2.1 Global Pharma Continuous Granulation Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Pharma Continuous Granulation Sales Value, by Application (2021–2032)

4.2.3 Global Pharma Continuous Granulation Sales Value, by Application (%), 2021–2032

4.3 Global Pharma Continuous Granulation Sales Volume by Application

4.3.1 Global Pharma Continuous Granulation Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Pharma Continuous Granulation Sales Volume, by Application (2021–2032)

4.3.3 Global Pharma Continuous Granulation Sales Volume, by Application (%), 2021–2032

4.4 Global Pharma Continuous Granulation Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Pharma Continuous Granulation Sales Value by Region

5.1.1 Global Pharma Continuous Granulation Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Pharma Continuous Granulation Sales Value by Region (2021–2026)

5.1.3 Global Pharma Continuous Granulation Sales Value by Region (2027–2032)

5.1.4 Global Pharma Continuous Granulation Sales Value by Region (%), 2021–2032

5.2 Global Pharma Continuous Granulation Sales Volume by Region

5.2.1 Global Pharma Continuous Granulation Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Pharma Continuous Granulation Sales Volume by Region (2021–2026)

5.2.3 Global Pharma Continuous Granulation Sales Volume by Region (2027–2032)

5.2.4 Global Pharma Continuous Granulation Sales Volume by Region (%), 2021–2032

5.3 Global Pharma Continuous Granulation Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Pharma Continuous Granulation Sales Value, 2021–2032

5.4.2 North America Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Pharma Continuous Granulation Sales Value, 2021–2032

5.5.2 Europe Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Pharma Continuous Granulation Sales Value, 2021–2032

5.6.2 Asia Pacific Pharma Continuous Granulation Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Pharma Continuous Granulation Sales Value, 2021–2032

5.7.2 South America Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pharma Continuous Granulation Sales Value, 2021–2032

5.8.2 Middle East & Africa Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pharma Continuous Granulation Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Pharma Continuous Granulation Sales Value and Sales Volume

6.2.1 Key Countries/Regions Pharma Continuous Granulation Sales Value, 2021–2032

6.2.2 Key Countries/Regions Pharma Continuous Granulation Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Pharma Continuous Granulation Sales Value, 2021–2032

6.3.2 United States Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Pharma Continuous Granulation Sales Value, 2021–2032

6.4.2 Europe Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Pharma Continuous Granulation Sales Value, 2021–2032

6.5.2 China Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.5.3 China Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Pharma Continuous Granulation Sales Value, 2021–2032

6.6.2 Japan Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Pharma Continuous Granulation Sales Value, 2021–2032

6.7.2 South Korea Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Pharma Continuous Granulation Sales Value, 2021–2032

6.8.2 Southeast Asia Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Pharma Continuous Granulation Sales Value, 2021–2032

6.9.2 India Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

6.9.3 India Pharma Continuous Granulation Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 LB Bohle

7.1.1 LB Bohle Company Information

7.1.2 LB Bohle Introduction and Business Overview

7.1.3 LB Bohle Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 LB Bohle Pharma Continuous Granulation Product Offerings

7.1.5 LB Bohle Recent Developments

7.2 GEA

7.2.1 GEA Company Information

7.2.2 GEA Introduction and Business Overview

7.2.3 GEA Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 GEA Pharma Continuous Granulation Product Offerings

7.2.5 GEA Recent Developments

7.3 LCI

7.3.1 LCI Company Information

7.3.2 LCI Introduction and Business Overview

7.3.3 LCI Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 LCI Pharma Continuous Granulation Product Offerings

7.3.5 LCI Recent Developments

7.4 LÖDIGE

7.4.1 LÖDIGE Company Information

7.4.2 LÖDIGE Introduction and Business Overview

7.4.3 LÖDIGE Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 LÖDIGE Pharma Continuous Granulation Product Offerings

7.4.5 LÖDIGE Recent Developments

7.5 Senieer

7.5.1 Senieer Company Information

7.5.2 Senieer Introduction and Business Overview

7.5.3 Senieer Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Senieer Pharma Continuous Granulation Product Offerings

7.5.5 Senieer Recent Developments

7.6 Thermo Fisher Scientific

7.6.1 Thermo Fisher Scientific Company Information

7.6.2 Thermo Fisher Scientific Introduction and Business Overview

7.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Thermo Fisher Scientific Pharma Continuous Granulation Product Offerings

7.6.5 Thermo Fisher Scientific Recent Developments

7.7 Syntegon

7.7.1 Syntegon Company Information

7.7.2 Syntegon Introduction and Business Overview

7.7.3 Syntegon Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Syntegon Pharma Continuous Granulation Product Offerings

7.7.5 Syntegon Recent Developments

7.8 Gericke

7.8.1 Gericke Company Information

7.8.2 Gericke Introduction and Business Overview

7.8.3 Gericke Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Gericke Pharma Continuous Granulation Product Offerings

7.8.5 Gericke Recent Developments

7.9 Bepex

7.9.1 Bepex Company Information

7.9.2 Bepex Introduction and Business Overview

7.9.3 Bepex Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Bepex Pharma Continuous Granulation Product Offerings

7.9.5 Bepex Recent Developments

7.10 EARTHTECHNICA

7.10.1 EARTHTECHNICA Company Information

7.10.2 EARTHTECHNICA Introduction and Business Overview

7.10.3 EARTHTECHNICA Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 EARTHTECHNICA Pharma Continuous Granulation Product Offerings

7.10.5 EARTHTECHNICA Recent Developments

7.11 Glatt

7.11.1 Glatt Company Information

7.11.2 Glatt Introduction and Business Overview

7.11.3 Glatt Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 Glatt Pharma Continuous Granulation Product Offerings

7.11.5 Glatt Recent Developments

7.12 FREUND

7.12.1 FREUND Company Information

7.12.2 FREUND Introduction and Business Overview

7.12.3 FREUND Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.12.4 FREUND Pharma Continuous Granulation Product Offerings

7.12.5 FREUND Recent Developments

7.13 Chansemt

7.13.1 Chansemt Company Information

7.13.2 Chansemt Introduction and Business Overview

7.13.3 Chansemt Pharma Continuous Granulation Sales, Revenue, Price and Gross Margin (2021–2026)

7.13.4 Chansemt Pharma Continuous Granulation Product Offerings

7.13.5 Chansemt Recent Developments

8 Industry Chain Analysis

8.1 Pharma Continuous Granulation Industrial Chain

8.2 Pharma Continuous Granulation Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Pharma Continuous Granulation Sales Model

8.5.2 Sales Channels

8.5.3 Pharma Continuous Granulation Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pharma Continuous Granulation Market Trends

Table 2. Pharma Continuous Granulation Market Drivers & Opportunities

Table 3. Pharma Continuous Granulation Market Challenges

Table 4. Pharma Continuous Granulation Market Restraints

Table 5. Global Pharma Continuous Granulation Revenue by Company (US$ Million), 2021–2026

Table 6. Global Pharma Continuous Granulation Revenue Market Share by Company (2021–2026)

Table 7. Global Pharma Continuous Granulation Sales Volume by Company (K Units), 2021–2026

Table 8. Global Pharma Continuous Granulation Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Pharma Continuous Granulation Price by Company (US$/Unit), 2021–2026

Table 10. Key Manufacturers Pharma Continuous Granulation Manufacturing Base and Headquarters

Table 11. Key Manufacturers Pharma Continuous Granulation Product Type

Table 12. Key Manufacturers Start of Mass Production of Pharma Continuous Granulation

Table 13. Global Pharma Continuous Granulation Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Pharma Continuous Granulation revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Pharma Continuous Granulation Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Pharma Continuous Granulation Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Pharma Continuous Granulation Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Pharma Continuous Granulation Sales Market Share in Value by Type (2021–2026)

Table 20. Global Pharma Continuous Granulation Sales Market Share in Value by Type (2027–2032)

Table 21. Global Pharma Continuous Granulation Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)

Table 22. Global Pharma Continuous Granulation Sales Volume by Type (K Units), 2021–2026

Table 23. Global Pharma Continuous Granulation Sales Volume by Type (K Units), 2027–2032

Table 24. Global Pharma Continuous Granulation Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Pharma Continuous Granulation Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Pharma Continuous Granulation Price by Type (US$/Unit), 2021–2026

Table 27. Global Pharma Continuous Granulation Price by Type (US$/Unit), 2027–2032

Table 28. Global Pharma Continuous Granulation Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Pharma Continuous Granulation Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Pharma Continuous Granulation Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Pharma Continuous Granulation Sales Market Share in Value by Application (2021–2026)

Table 32. Global Pharma Continuous Granulation Sales Market Share in Value by Application (2027–2032)

Table 33. Global Pharma Continuous Granulation Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)

Table 34. Global Pharma Continuous Granulation Sales Volume by Application (K Units), 2021–2026

Table 35. Global Pharma Continuous Granulation Sales Volume by Application (K Units), 2027–2032

Table 36. Global Pharma Continuous Granulation Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Pharma Continuous Granulation Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Pharma Continuous Granulation Price by Application (US$/Unit), 2021–2026

Table 39. Global Pharma Continuous Granulation Price by Application (US$/Unit), 2027–2032

Table 40. Global Pharma Continuous Granulation Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Pharma Continuous Granulation Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Pharma Continuous Granulation Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Pharma Continuous Granulation Sales Value by Region (%), 2021–2026

Table 44. Global Pharma Continuous Granulation Sales Value by Region (%), 2027–2032

Table 45. Global Pharma Continuous Granulation Sales Volume by Region (K Units): 2021 vs 2025 vs 2032

Table 46. Global Pharma Continuous Granulation Sales Volume by Region (K Units), 2021–2026

Table 47. Global Pharma Continuous Granulation Sales Volume by Region (K Units), 2027–2032

Table 48. Global Pharma Continuous Granulation Sales Volume by Region (%), 2021–2026

Table 49. Global Pharma Continuous Granulation Sales Volume by Region (%), 2027–2032

Table 50. Global Pharma Continuous Granulation Average Price by Region (US$/Unit), 2021–2026

Table 51. Global Pharma Continuous Granulation Average Price by Region (US$/Unit), 2027–2032

Table 52. Key Countries/Regions Pharma Continuous Granulation Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Pharma Continuous Granulation Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Pharma Continuous Granulation Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Pharma Continuous Granulation Sales Volume, (K Units), 2021–2026

Table 56. Key Countries/Regions Pharma Continuous Granulation Sales Volume, (K Units), 2027–2032

Table 57. LB Bohle Company Information

Table 58. LB Bohle Introduction and Business Overview

Table 59. LB Bohle Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 60. LB Bohle Pharma Continuous Granulation Product Offerings

Table 61. LB Bohle Recent Developments

Table 62. GEA Company Information

Table 63. GEA Introduction and Business Overview

Table 64. GEA Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 65. GEA Pharma Continuous Granulation Product Offerings

Table 66. GEA Recent Developments

Table 67. LCI Company Information

Table 68. LCI Introduction and Business Overview

Table 69. LCI Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 70. LCI Pharma Continuous Granulation Product Offerings

Table 71. LCI Recent Developments

Table 72. LÖDIGE Company Information

Table 73. LÖDIGE Introduction and Business Overview

Table 74. LÖDIGE Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 75. LÖDIGE Pharma Continuous Granulation Product Offerings

Table 76. LÖDIGE Recent Developments

Table 77. Senieer Company Information

Table 78. Senieer Introduction and Business Overview

Table 79. Senieer Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 80. Senieer Pharma Continuous Granulation Product Offerings

Table 81. Senieer Recent Developments

Table 82. Thermo Fisher Scientific Company Information

Table 83. Thermo Fisher Scientific Introduction and Business Overview

Table 84. Thermo Fisher Scientific Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 85. Thermo Fisher Scientific Pharma Continuous Granulation Product Offerings

Table 86. Thermo Fisher Scientific Recent Developments

Table 87. Syntegon Company Information

Table 88. Syntegon Introduction and Business Overview

Table 89. Syntegon Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 90. Syntegon Pharma Continuous Granulation Product Offerings

Table 91. Syntegon Recent Developments

Table 92. Gericke Company Information

Table 93. Gericke Introduction and Business Overview

Table 94. Gericke Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 95. Gericke Pharma Continuous Granulation Product Offerings

Table 96. Gericke Recent Developments

Table 97. Bepex Company Information

Table 98. Bepex Introduction and Business Overview

Table 99. Bepex Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 100. Bepex Pharma Continuous Granulation Product Offerings

Table 101. Bepex Recent Developments

Table 102. EARTHTECHNICA Company Information

Table 103. EARTHTECHNICA Introduction and Business Overview

Table 104. EARTHTECHNICA Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 105. EARTHTECHNICA Pharma Continuous Granulation Product Offerings

Table 106. EARTHTECHNICA Recent Developments

Table 107. Glatt Company Information

Table 108. Glatt Introduction and Business Overview

Table 109. Glatt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 110. Glatt Pharma Continuous Granulation Product Offerings

Table 111. Glatt Recent Developments

Table 112. FREUND Company Information

Table 113. FREUND Introduction and Business Overview

Table 114. FREUND Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 115. FREUND Pharma Continuous Granulation Product Offerings

Table 116. FREUND Recent Developments

Table 117. Chansemt Company Information

Table 118. Chansemt Introduction and Business Overview

Table 119. Chansemt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 120. Chansemt Pharma Continuous Granulation Product Offerings

Table 121. Chansemt Recent Developments

Table 122. Key Raw Materials Lists

Table 123. Key Suppliers of Raw Materials Lists

Table 124. Pharma Continuous Granulation Downstream Customers

Table 125. Pharma Continuous Granulation Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharma Continuous Granulation Product Picture

Figure 2. Global Pharma Continuous Granulation Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 4. Global Pharma Continuous Granulation Sales Volume (K Units), 2021–2032

Figure 5. Global Pharma Continuous Granulation Sales Price (US$/Unit), 2021–2032

Figure 6. Pharma Continuous Granulation Report Years Considered

Figure 7. Global Pharma Continuous Granulation Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Pharma Continuous Granulation Sales Volume Ranking of Players (K Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharma Continuous Granulation Revenue in 2025

Figure 10. Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Dry Method Picture

Figure 12. Wet Method Picture

Figure 13. Global Pharma Continuous Granulation Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Pharma Continuous Granulation Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Pharma Continuous Granulation Sales Volume by Type (K Units), 2021 vs 2025 vs 2032

Figure 16. Global Pharma Continuous Granulation Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Pharma Continuous Granulation Price by Type (US$/Unit), 2021–2032

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Capsules

Figure 20. Product Picture of Others

Figure 21. Global Pharma Continuous Granulation Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Pharma Continuous Granulation Sales Value Market Share by Application, 2025 & 2032

Figure 23. Global Pharma Continuous Granulation Sales Volume by Application (K Units), 2021 vs 2025 vs 2032

Figure 24. Global Pharma Continuous Granulation Sales Volume Market Share by Application, 2025 & 2032

Figure 25. Global Pharma Continuous Granulation Price by Application (US$/Unit), 2021–2032

Figure 26. North America Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 27. North America Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

Figure 28. Europe Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 29. Europe Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

Figure 30. Asia Pacific Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 31. Asia Pacific Pharma Continuous Granulation Sales Value by Region (%), 2025 vs 2032

Figure 32. South America Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 33. South America Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

Figure 34. Middle East & Africa Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 35. Middle East & Africa Pharma Continuous Granulation Sales Value by Country (%), 2025 vs 2032

Figure 36. Key Countries/Regions Pharma Continuous Granulation Sales Value (%), 2021–2032

Figure 37. Key Countries/Regions Pharma Continuous Granulation Sales Volume (%), 2021–2032

Figure 38. United States Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 39. United States Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 40. United States Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 41. Europe Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 42. Europe Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 43. Europe Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 44. China Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 45. China Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 46. China Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 47. Japan Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 48. Japan Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 49. Japan Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 50. South Korea Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 51. South Korea Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 52. South Korea Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 53. Southeast Asia Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 54. Southeast Asia Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 55. Southeast Asia Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 56. India Pharma Continuous Granulation Sales Value (US$ Million), 2021–2032

Figure 57. India Pharma Continuous Granulation Sales Value by Type (%), 2025 vs 2032

Figure 58. India Pharma Continuous Granulation Sales Value by Application (%), 2025 vs 2032

Figure 59. Pharma Continuous Granulation Industrial Chain

Figure 60. Pharma Continuous Granulation Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharma Continuous Granulation market? zhanKai

The top companies in the global Pharma Continuous Granulation market are LB Bohle、GEA、LCI.

Related Reports

Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 158
USD 4900.00
(Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Continuous Granulation market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 95
USD 4250.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2026
The global Pharma Continuous Granulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 137
USD 2900.00
(Single User License)
Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 155
USD 4900.00
(Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Continuous Granulation market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 94
USD 4250.00
(Single User License)
Pharma Continuous Granulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 112
USD 3950.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2025
The global market for Pharma Continuous Granulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
Global and United States Pharma Continuous Granulation Market Report & Forecast 2024-2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 130
USD 4350.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2024
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 105
USD 2900.00
(Single User License)
Global Pharma Continuous Granulation Market Insights, Forecast to 2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 169
USD 4900.00
(Single User License)

Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 158
USD 4900.00 (Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Continuous Granulation market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 95
USD 4250.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2026
The global Pharma Continuous Granulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 137
USD 2900.00 (Single User License)
Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 155
USD 4900.00 (Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Continuous Granulation market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 94
USD 4250.00 (Single User License)
Pharma Continuous Granulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 112
USD 3950.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2025
The global market for Pharma Continuous Granulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 99
USD 2900.00 (Single User License)
Global and United States Pharma Continuous Granulation Market Report & Forecast 2024-2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 130
USD 4350.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2024
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 105
USD 2900.00 (Single User License)
Global Pharma Continuous Granulation Market Insights, Forecast to 2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 169
USD 4900.00 (Single User License)